H2020-JTI-IMI2-2016-09-two-stage · IDENTIFICATION AND VALIDATION OF BIOMARKERS FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ACROSS THE SPECTRUM OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) · Opportunity · GRANTIBASE · GRANTIBASE
H2020-JTI-IMI2-2016-09-two-stage · IDENTIFICATION AND VALIDATION OF BIOMARKERS FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ACROSS THE SPECTRUM OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Horizon 2020Horizon 2020€117.7m
Specific Challenge:The central challenge to be addressed is to establish and validate non-invasive markers for classifying and evaluating subjects with NAFLD, and in particular to identify amongst those with NAFLD, individuals who have Nonalcoholic steatohepatitis (NASH). Identifying and validating…
